Quick Answer
CONMED Corp reported Cash And Cash Equivalents At Carrying Value of $25.86 million for the year ending 2019.
- CONMED Corp showed an increase of +47.7% in Cash And Cash Equivalents At Carrying Value from 2018 to 2019.
- This data is from CONMED Corp's annual report (Form 10-K), filed with the SEC on February 24, 2020.
- XBRL data for this metric is available from 2008 to 2019 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $8.49 million | Q3 2010: $16.52 million | Q1 2011: $17.94 million | Q2 2011: $24.33 million | Q3 2011: $39.88 million | Q1 2012: $19.45 million | Q2 2012: $16.25 million | Q3 2012: $19.82 million | Q1 2013: $32.36 million | Q2 2013: $38.12 million | Q3 2013: $49.83 million | Q1 2014: $56.32 million | Q2 2014: $60.41 million | Q3 2014: $64.61 million | Q1 2015: $65.73 million | Q2 2015: $62.22 million | Q3 2015: $65.33 million | Q1 2016: $19.89 million | Q2 2016: $23.30 million | Q3 2016: $26.95 million | Q1 2017: $34.66 million | Q2 2017: $40.14 million | Q3 2017: $44.03 million | Q1 2018: $21.13 million | Q2 2018: $23.40 million | Q3 2018: $29.69 million | Q1 2019: $23.41 million | Q2 2019: $22.55 million | Q3 2019: $30.07 million.
- Over the full 12 years of available data (2008 to 2019), CONMED Corp's Cash And Cash Equivalents At Carrying Value has grown by 118.9%.
- Historical annual values: Fiscal year 2019: $25.86 million | Fiscal year 2018: $17.51 million | Fiscal year 2017: $32.62 million | Fiscal year 2016: $27.43 million | Fiscal year 2015: $72.50 million | Fiscal year 2014: $66.33 million | Fiscal year 2013: $54.44 million | Fiscal year 2012: $23.72 million | Fiscal year 2011: $26.05 million | Fiscal year 2010: $12.42 million | Fiscal year 2009: $10.10 million | Fiscal year 2008: $11.81 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: